tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical, Inc. (RARE)
:RARE
US Market
Advertisement

Ultragenyx Pharmaceutical (RARE) Ownership - Who Owns Ultragenyx Pharmaceutical?

Compare
932 Followers

Ultragenyx Pharmaceutical (RARE) Ownership Overview

4.09%26.76%1.30%14.31%53.54%
1.30% Other Institutional Investors
14.31% ETFs
53.54% Public Companies and
Individual Investors
The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail, and individual investors. Approximately 42.37% of the company’s stock is owned by Institutional Investors, 4.09% is owned by Insiders, and 53.54% is owned by Public Companies and Individual Investors.
The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail, and individual investors. Approximately 28.06% of the company’s stock is owned by Institutional Investors, 4.09% is owned by Insiders, and 14.31% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 23, 2025
xxxxxxxxxxxxx
$89923
May 05, 2025
xxxxxxxxxxxxx
$8497
Mar 10, 2025
xxxxxxxxxxxxx
$72114
Mar 04, 2025
xxxxxxxxxxxxx
$275582

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,200,026Institution8.67%223,040,707
7,617,739Institution8.06%207,202,501
4,163,561Institution4.40%113,248,859
2,800,716Insider2.96%76,179,475
2,401,171Institution2.54%65,311,851
2,025,900Institution2.14%55,104,480
2,001,985Institution2.12%54,453,992
1,576,114Institution1.67%42,870,301
1,551,837Institution1.64%42,209,966
1,074,364Institution1.14%29,222,701

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,617,739Institution8.06%207,202,501
2,025,900Institution2.14%55,104,480
2,001,985Institution2.12%54,453,992
1,551,837Institution1.64%42,209,966
974,312Institution1.03%26,501,286
922,438Institution0.98%25,090,314
892,486Institution0.94%24,275,619
791,751Institution0.84%21,535,627
783,990Institution0.83%21,324,528
629,609Institution0.67%17,125,365

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,854,794Institution3.02%97,148,640
2,217,811Institution2.35%75,472,108
1,432,401Institution1.52%48,744,606
1,222,630Institution1.29%41,606,099
1,012,829Institution1.07%29,888,584
582,669Institution0.62%15,848,597
534,305Institution0.57%14,533,096
445,381Institution0.47%13,143,193
338,633Institution0.36%9,210,818
312,823Institution0.33%8,508,786

FAQ

Who Owns Ultragenyx Pharmaceutical, Inc. (RARE)?
According to the latest TipRanks data, approximately 1.30% of the company's stock is held by institutional investors, 4.09% is held by insiders, and 53.54% is held by retail investors.
    What percentage of Ultragenyx Pharmaceutical, Inc. (RARE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.30% of Ultragenyx Pharmaceutical, Inc. (RARE) stock is held by institutional investors.
      What percentage of Ultragenyx Pharmaceutical, Inc. (RARE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 53.54% of Ultragenyx Pharmaceutical, Inc. (RARE) stock is held by retail investors.
        Who owns the most shares of Ultragenyx Pharmaceutical, Inc. (RARE)?
        Vanguard owns the most shares of Ultragenyx Pharmaceutical, Inc. (RARE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis